Innovent Biologics, Inc.

HKEX:1801.HK

39.05 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 2,745.69310,052.0951,332.2657,655.6571,016.1659,162.8231,352.0438,317.9471,359.4088,377.0954,464.70211,164.0341,276.1787,763.8334,633.2864,633.2862,425.8064,232.6423,431.0423,431.0424,525.3524,525.3521,887.1141,887.114510.471510.471-1,795.241
Short Term Investments 7,374.088917.5346,318.747870.8377,248.4293.2135,678.43706,581.485638.2136,219.33206,771.952357.2971,561.1151,561.1152,269.355462.51953.553.582.31772.309181.4081,702.075809.484809.4843,590.482
Cash and Short Term Investments 10,119.78110,969.6297,651.0128,526.4948,264.5949,166.0367,030.488,317.9477,940.8939,015.30810,684.03411,164.0348,048.138,121.136,194.4016,194.4014,695.1614,695.1613,484.5423,484.5424,525.3524,597.6612,068.5223,770.5971,319.9551,319.9551,795.241
Net Receivables 1,005.8911,005.8911,015.5021,015.502575.269575.2691,186.6481,186.648968.405968.4051,002.4551,002.455475.378475.378380.025380.025250.039250.039179.778179.7787.5057.5053.5373.537-809.484-809.4840
Inventory 968.088968.0881,300.0271,300.0271,428.8821,428.8821,476.9151,476.9151,347.241,347.241,101.6361,101.636705.658705.658467.136467.136358.597358.597231.581231.58166.12166.12148.9848.9857.72257.7220
Other Current Assets 484.3771,401.9111,414.1211,414.121339.734339.734213.024213.024858.109858.109164.398164.398521.812521.8121,682.0251,682.025614.145614.145206.868206.86814.97414.974195.889195.889877.562877.5620
Total Current Assets 13,427.98513,427.98511,385.30711,385.30711,506.70811,506.70811,194.53411,194.53411,550.84911,550.84913,432.52313,432.5239,466.6819,466.6817,162.4727,162.4725,455.4235,455.4234,049.2694,049.2694,686.2614,686.2613,837.5953,837.5951,445.7551,445.7551,795.241
Non-Current Assets:
Property, Plant & Equipment, Net 4,851.9034,656.3844,450.3224,187.1344,060.7193,826.1463,605.4143,341.1353,375.7573,089.8482,723.5432,327.632,183.4811,911.2031,531.0471,474.6941,521.1531,436.3041,305.2821,241.3261,123.1671,078.053882.941782.912821.838761.8180
Goodwill 000000000000000000000000000
Intangible Assets 1,270.26727.7881,190.4451,190.4451,198.16330.046815.502815.502772.19419.74896.91496.91432.625035.20735.207000052.842053.466054.0900
Goodwill and Intangible Assets 1,270.26727.7881,190.4451,190.4451,198.16330.046815.502815.502772.19419.74896.91496.91432.625035.20735.207000052.842053.466054.0900
Long Term Investments 794.089794.089-5,682.101636.646713.215630.197465.001397.048511.905417.255-6,173.90545.427-6,759.0112.9422.1761.9842.221.98400001,835.9450000
Tax Assets -195.51900000004,359.886000001,881.7560000000-788.2410000
Other Non-Current Assets 478.6351,721.1146,553.063497.504110.041,595.74878.184410.416-4,326.8771,166.0136,377.507554.0886,911.219444.17-1,658.466279.835251.733336.818250.533314.489250.307348.263-927.932273.267135.533249.643-1,795.241
Total Non-Current Assets 7,199.3757,199.3756,511.7296,511.7296,082.1376,082.1374,964.1014,964.1014,692.8644,692.8643,024.0593,024.0592,368.3152,368.3151,791.721,791.721,775.1061,775.1061,555.8151,555.8151,426.3161,426.3161,056.1791,056.1791,011.4611,011.461-1,795.241
Total Assets 20,627.3620,627.3617,897.03617,897.03617,588.84517,588.84516,158.63516,158.63516,243.71316,243.71316,456.58216,456.58211,834.99611,834.9968,954.1928,954.1927,230.5297,230.5295,605.0845,605.0846,112.5776,112.5774,893.7744,893.7742,457.2162,457.2160
Liabilities & Equity:
Current Liabilities:
Account Payables 372.549372.549216.413216.413325.622325.622236.355236.355195.05195.05277.334277.334120.62120.62196.065196.06584.27584.27560.39360.39342.82142.82136.63936.63934.83634.8360
Short Term Debt 1,220.331,195.155477.117450.1914.392888873.946858387.273365384.937370271.157255161.4514632.551718.0621110101010550
Tax Payables 194.049067.73061.015023.649092.77600.35605.68505.0101.7510001.082026.50401.08200
Deferred Revenue -25.1750000000-1,034.89700000-247.6240-146.8290-102.4170-96.8530-331.1070-30.78300
Other Current Liabilities 2,909.1122,909.1122,178.9342,205.9512,259.1842,285.5762,371.4692,387.4153,502.6212,489.9971,579.4671,594.4041,094.0741,110.231974.994742.821,073.56942.281697.425602.07714.353617.52,054.651,723.543154.223123.440
Total Current Liabilities 4,476.8164,476.8162,872.4642,872.4643,499.1983,499.1983,481.773,481.773,050.0473,050.0472,241.7382,241.7381,485.8511,485.8511,084.8851,084.8851,043.5561,043.556673.463673.463670.321670.3211,770.1821,770.182163.276163.2760
Non-Current Liabilities:
Long Term Debt 2,400.1992,400.1992,975.1812,975.1812,314.1162,314.1161,892.1541,892.1542,109.6532,109.6531,471.2641,471.264935.411935.411809.403809.403832.538832.538805.619805.6197827826874,237.1165053,556.0920
Deferred Revenue Non-Current 960.05101,034.6460883.27701,187.8270753.2740838.2510633.9640655.3390598.3040597.4820465.8420460.3510359.97600
Deferred Tax Liabilities Non-Current -960.051000000000-838.2510-633.9640-19.7650-16.5180-14.9940-15.95503,533.203,039.88100
Other Non-Current Liabilities 1,222.7641,222.764231.5281,266.174162.3051,045.5825.7941,193.6210.342753.616838.251838.251633.964633.96419.765655.33916.518598.30414.994597.48215.955465.84216.916460.35111.211359.9760
Total Non-Current Liabilities 3,622.9633,622.9634,241.3554,241.3553,359.6983,359.6983,085.7753,085.7752,863.2692,863.2692,309.5152,309.5151,569.3751,569.3751,464.7421,464.7421,430.8421,430.8421,403.1011,403.1011,247.8421,247.8424,697.4674,697.4673,916.0683,916.0680
Total Liabilities 8,099.7798,099.7797,113.8197,113.8196,858.8966,858.8966,567.5456,567.5455,913.3165,913.3164,551.2534,551.2533,055.2263,055.2262,549.6272,549.6272,474.3982,474.3982,076.5642,076.5641,918.1631,918.1636,467.6496,467.6494,079.3444,079.3440
Equity:
Preferred Stock 000000000010,562.10209,761.578000145.650248.4280293.2890304.4250504.63800
Common Stock 0.1120.1120.1060.1060.1050.1050.1010.1010.1010.1010.10.10.0970.0970.0930.0930.0870.0870.0790.0790.0790.0790.0140.0140.0080.0080
Retained Earnings -15,767.568-15,767.568-14,878.804-14,878.804-16,681.37-14,739.655-15,823.177-13,510.853-15,409.567-12,560.385-11,157.299-11,157.299-9,981.989-9,981.989-10,521.71-9,591.762-10,053.78-8,983.568-9,075.756-7,978.024-8,268.983-7,263.618-1,716.49-1,448.232-1,791.657-1,492.1260
Accumulated Other Comprehensive Income/Loss 12,527.469970.541761.76761.76763.861763.861558.152558.152397.023397.023595.197595.197220.411220.4117.177.17-145.65-145.65-248.428-248.428-293.289-293.289-304.425-304.425-504.638-504.638-1,383.924
Other Total Stockholders Equity 15,767.56827,324.49624,900.15524,900.15526,647.35324,705.63824,856.01422,543.6925,342.8422,493.65811,905.22922,467.3318,779.67318,541.25116,919.01215,989.06414,809.82413,885.26212,604.19711,754.89312,463.31811,751.242142.601178.768-150.89954.208425.706
Total Shareholders Equity 12,527.58112,527.58110,783.21710,783.21710,729.94910,729.9499,591.099,591.0910,330.39710,330.39711,905.32911,905.3298,779.778,779.776,404.5656,404.5654,756.1314,756.1313,528.523,528.524,194.4144,194.414-1,573.875-1,573.875-1,942.548-1,942.548-958.218
Total Equity 12,527.58112,527.58110,783.21710,783.21710,729.94910,729.9499,591.099,591.0910,330.39710,330.39711,905.32911,905.3298,779.778,779.776,404.5656,404.5654,756.1314,756.1313,528.523,528.524,194.4144,194.414-1,573.875-1,573.875-1,622.128-1,622.128-958.218
Total Liabilities & Shareholders Equity 20,627.3620,627.3617,897.03617,897.03617,588.84517,588.84516,158.63516,158.63516,243.71316,243.71316,456.58216,456.58211,834.99611,834.9968,954.1928,954.1927,230.5297,230.5295,605.0845,605.0846,112.5776,112.5774,893.7744,893.7742,457.2162,457.216-958.218